Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
1. Gepotidacin (Blujepa) leads to rapid clinical response in female patients with uncomplicated urinary tract infections (uUTIs) and is generally ...
Tag: drug
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup: Enbumyst Nasal Spray Approval, FDA Targets Drug Ads, Samsung BioLogics Contract, Wegovy Mental Health Benefits [September 17 2025]
Corstasis’ Enbumyst nasal spray approved for edema The Food and Drug Administration has approved Enbumyst, a bumetanide nasal spray, for ...
Intellia Therapeutics: NTLA-2002 CRISPR-based therapy reduces rates of Hereditary Angioedema (HAE) attacks
CRISPR gene editing based treatment reduced HAE attacks rates by up to 80%. NTLA-2002 was well tolerated by patients. The ...
Unhealthy alcohol use may be common amongst patients in the emergency department
1. This study found that unhealthy alcohol use was relatively common in the general emergency department patient population at Highland ...
Co-occurring substance use disorders are common in pregnant women
1. Approximately 7% of pregnant women were diagnosed with at least one substance use disorder at delivery. 2. Many patients ...
Exercise and dance may reduce cravings associated with methamphetamine abuse in women
1. In this randomized controlled trial, dance and exercise interventions reduced subjective drug cravings compared to the control group. 2. ...
Wellness Check: Addictions
2 Minute Medicine is pleased to announce that we are launching Wellness Check, a new series dedicated to exploring new ...
Ambrisentan found ineffective against idiopathic pulmonary fibrosis
Image: PD/ Fibrotic lung 1. Ambrisentan is ineffective in delaying disease progression in idiopathic pulmonary fibrosis (IPF). 2. Compared to placebo, ...
